63323-413Level 3
Neostigmine Methylsulfate (Neostigmine Methylsulfate)
**Product type:** Human Prescription Drug
**Active ingredient:** NEOSTIGMINE METHYLSULFATE
**Strength:** .5 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** Fresenius Kabi USA, LLC
**Marketing category:** NDA (NDA203629)
**Pharmacologic class:** Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/63323-413Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.